臺北醫學大學，簡稱臺北醫大、北醫大、北醫，是一所位於臺灣臺北市信義區的私立醫學大學。北醫大前身係1960年胡水旺、徐千田創辦的「臺北醫學院」；2000年獲准升格，改名「臺北醫學大學」，現為優久聯盟、臺北聯合大學系統之成員學校。

During the past decade, Taipei Medical University conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 4 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 4 clinical trials were completed. i.e. 14.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Taipei Medical University" #1 sponsor was "Taipei Medical University" with 29 trials, followed by "Taipei Medical University WanFang Hospital" with 7 trials sponsored, "Ono Pharmaceutical Co. Ltd" with 4 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "AVEO Pharmaceuticals, Inc." with 3 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Taipei Medical University" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "National Health Research Institutes, Taiwan" with 2 trials as a collaborator, "Biodesix, Inc." with 1 trials as a collaborator, "Cathay General Hospital" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Taipei Medical University" are "Stroke" (5 trials), "Insomnia" (3 trials), "Mild Cognitive Impairment" (3 trials), "Traumatic Brain Injury" (3 trials) and "Cognitive Impairment" (2 trials). Many other conditions were trialed in "Taipei Medical University" in a lesser frequency.

Most popular intervention types in "Taipei Medical University" are "Behavioral" (17 trials), "Drug" (9 trials), "Other" (9 trials), "Dietary Supplement" (4 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Exercise" (3 trials), "ONO-4538" (3 trials), "Capecitabine" (2 trials) and "Oxaliplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Taipei Medical University" are 43 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are 24 active trials in "Taipei Medical University". 3 are not yet recruiting, 13 are recruiting, 3 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 14 completed trials in Taipei Medical University, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Taipei Medical University, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 28 trials that are defined as “Not Applicable".

Taipei Medical University has several departments that took part in Clinical trials: "Department of rehabilitation, WanFang Hospital" - 3 trials, "Division of Nephrology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital" - 2 trials